FDA Is Not An "Evil Empire," Biogen Idec Says; Tysabri Data Enhanced Relationship With Agency
This article was originally published in The Pink Sheet Daily
Executive Summary
Biogen Idec Senior VP-Development Bert Adelman, MD, took time to defend FDA during the company's analyst day Nov. 30